15:52 Oct 04
Abbott India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Abbott India Ltd.
77/100 High Financial Strength
Quality20/100 Expensive Valuation
Valuation49/100 Technically Neutral
TechnicalSWOT
Strength
10
Weakness
1
Opportunity
0
Threat
3
59.72K
Market Cap (Cr)
48.20
PE Ratio
16.15
Price to Book Ratio
40.57
RSI
0.00 %
Net Profit Margin
Rating Based on 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 31833.33 with a high estimate of 32500 and low estimate of 31000
Current 28104.55
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
